NCT06012435
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06012435
Title A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Acronym Be6A Lung-01
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Seagen, a wholly owned subsidiary of Pfizer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ROU | POL | NOR | NLD | ITA | ISR | HUN | GRC | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BRA | BEL | AUT | AUS | ARG


No variant requirements are available.